Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-19-031006

Options or other derivatives

  • Director acquired 9,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Swirsky Douglas J Director 2019-06-13 Grant or award · Stock option (right to buy) +9,750 9,750 D
Loading xslF345X03/tv523607_4.xml…